Skip to content
Rowan University logo

Rowan Innovation Venture Fund (RIVF)

Visit program ↗Check the fit ↓

Key numbers

Funding range

$25,000

Convertible Note

Equity

Varies by investment

Application

Rolling

Campus Wide

Last activity

2026

Medium confidence

Keep this on your radar Deadline reminders ↓

Reminders

Rowan Innovation Venture Fund (RIVF)

Get an email before a director-verified deadline for this program, this school, or this state. The program never sees your address.

Student experiences · Read or add a note

Student notes

Rowan Innovation Venture Fund (RIVF)

No posts yet.

    Post what happened. A .edu account is required. Your name and email stay off this page.

    Rating

    0/280

    Program details

    Rowan Innovation Venture Fund (RIVF)

    Program Type

    venture-fund

    Institutional Scope

    Rowan-affiliated startups (students, faculty, alumni). High-growth ventures.

    Description

    $25 million fund dedicated to supporting Rowan-affiliated startups. Provides convertible notes (e.g., $25K to Rohrer NVC winners) and additional funding for high-growth ventures. Works closely with RCIE and AccelerateRU — accelerator participants can apply for additional RIVF funding. Managing Director: Ernest Holtzheimer (Member at Eckert Seamans). Advisor: Shawn Hill (Co-founder, Garden State Venture Partners).

    Key Details

    Detail Value
    Fund size $25 million
    Instruments Convertible notes
    Deployment Competition awards + direct applications via AccelerateRU
    Managing Director Ernest Holtzheimer
    Integration RCIE, AccelerateRU, NVC

    Resources Provided

    • Convertible note investment
    • Connection to RCIE programming
    • Managing Director guidance

    Funding Details

    Convertible notes (equity-based). $25K note to NVC winner standard.

    Curriculum / Structure

    Deal-by-deal. NVC winners automatically considered. AccelerateRU participants can apply.

    Eligibility

    Rowan-affiliated high-growth startups.

    Related Programs

    Additional research notesShow

    Evidence